Skip to main content
. 2022 Jun 14;48:95. doi: 10.1186/s13052-022-01278-7

Table 8.

Dupilumab in adolescents with moderate to severe dermatitis

Main clinical trials
Phase 2 open-label study R 668-AD1412
Pharmacokinetics, safety, efficacy in patients aged 6 to 17 years
Liberty ADOL
Phase 3 pilot monotherapy study R 668-AD 1526
Safety and efficacy in patients aged 12 to 17 years
Liberty AD PED OLE
Phase 3 study Open-Label Extension (OLE) R 668-AD 1434
Safety and efficacy in patients 6 months to <18 years